|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.20 USD | +107.02% |
|
+15.46% | +15.23% |
| 07-31 | Top Midday Gainers | MT |
| 07-31 | Replimune's RP1 Likely to Win US FDA Approval for Advanced Melanoma, Wedbush Says | MT |
| Market Cap | 940M 817M 761M 699M 1.32B 89.77B 1.34B 8.97B 3.52B 44.69B 3.53B 3.45B 150B | P/E 2027 * |
-4.34x | P/E 2028 * | -8.93x |
|---|---|---|---|---|---|
| Enterprise Value | 923M 803M 747M 686M 1.3B 88.15B 1.32B 8.81B 3.46B 43.88B 3.47B 3.39B 147B | EV / Sales 2027 * |
22.1x | EV / Sales 2028 * | 9.12x |
| Free-Float |
98.01% | Yield 2027 * |
-
| Yield 2028 * | - |
Last Transcript: Replimune Group, Inc.
| 1 day | +107.02% | ||
| 1 week | +15.46% | ||
| 1 month | -3.28% | ||
| 3 months | +348.00% | ||
| 6 months | +60.57% | ||
| Current year | +15.23% |
| 1 week | 4.76 |  | 12.5 |
| 1 month | 4.76 | | 12.5 |
| Current year | 1.5 | | 12.5 |
| 1 year | 1.5 | | 12.5 |
| 3 years | 1.5 | | 21.32 |
| 5 years | 1.5 | | 36.97 |
| 10 years | 1.5 | | 54.85 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sushil Patel
CEO | Chief Executive Officer | 55 | 2024-03-31 |
Emily Hill
DFI | Director of Finance/CFO | 46 | 2023-09-18 |
| Chief Tech/Sci/R&D Officer | 60 | 2022-11-30 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 54 | 2024-03-31 | |
Kapil Dhingra
BRD | Director/Board Member | 66 | 2017-06-30 |
Dieter Weinand
CHM | Chairman | 65 | 2020-03-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 4/1/26 | Free | Director | 44,500 | 0.0570% | ||
| 2/18/26 | Don | Founder | 25,000 | 0.0320% | ||
| 12/19/25 | Free | Chief Financial Officer | 60,000 | 0.0769% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +107.02% | +15.46% | +47.37% | -47.47% | 940M | |
| -1.40% | +2.59% | -1.71% | +12.94% | 48.53B | |
| -2.41% | -0.90% | +411.96% | +472.09% | 39.87B | |
| -1.16% | +12.96% | +28.81% | +7.27% | 38.68B | |
| -1.88% | -3.03% | +5.69% | +66.52% | 35.13B | |
| -1.74% | +5.12% | +14.44% | +44.64% | 29.79B | |
| -0.21% | -4.04% | +36.40% | +126.06% | 16.11B | |
| -2.85% | -3.92% | - | - | 16.08B | |
| -0.64% | +2.65% | +3.40% | +14.79% | 13.61B | |
| -1.19% | -1.32% | -1.73% | -34.97% | 12.62B | |
| Average | +9.35% | +2.49% | +60.51% | +73.54% | 25.14B | |
| Weighted average by Cap. | -1.19% | +2.08% | +79.65% | +106.86% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 41.82M 36.36M 33.84M 31.07M 58.67M 3.99B 59.58M 399M 157M 1.99B 157M 154M 6.67B | 103M 89.64M 83.43M 76.6M 145M 9.84B 147M 983M 386M 4.9B 387M 379M 16.43B |
| Net income | -231M -201M -187M -172M -324M -22.05B -329M -2.2B -864M -10.98B -867M -848M -36.8B | -148M -129M -120M -110M -208M -14.13B -211M -1.41B -554M -7.03B -556M -544M -23.58B |
| Net Debt | -17M -14.78M -13.76M -12.63M -23.85M -1.62B -24.22M -162M -63.63M -808M -63.85M -62.44M -2.71B | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-31 | US$11.20 | +107.02% | 33,629,890 |
| 26-07-29 | US$5.410 | +1.12% | 14,296,364 |
| 26-07-28 | US$5.350 | -38.01% | 24,020,460 |
| 26-07-27 | US$8.630 | -11.03% | 8,460,299 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- REPL Stock
Select your edition
All financial news and data tailored to specific country editions
